Lupin is one of India’ s top 10 pharmaceutical companies and one of the most prolific introducer of new products in the Indian marketplace. As a leading global player in the Anti-TB, Cephalosporin and Cardiovascular segments, the company operates in vital segments with global footprints in over 50 countries, through its onshore presence and business alliances. It also develops strong competencies in the anti-diabetic and anti-asthma segments.

Acquired Companies: Generic Health, Multicare Pharmaceuticals Philippines Inc. , Kyowa Pharmaceutical Industry Co., Ltd.